StonvexLoading…
StonvexStonvexStonvexCore line items from MNR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.18B | $969.63M | $762.31M | $937.41M |
Operating Income | $244.95M | $290.99M | $359.14M | $522.38M |
Net Income | $142.98M | $185.18M | $68.52M | $516.84M |
EPS (Diluted) | $1.09 | $1.90 | $0.72 | Not available |
Total Assets | $3.78B | $2.34B | $2.30B | $887.86M |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $42.63M | $105.78M | $152.79M | $29.42M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 131.54M | 97.70M | 94.91M | Not available |